Cargando…

Multiparticulate Systems of Meloxicam for Colonic Administration in Cancer or Autoimmune Diseases

The aim of this research is the development of new colonic release systems of meloxicam (MLX) a non-steroidal anti-inflammatory drug (NSAIDs) with pH and time-dependent vehicles for cancer or autoimmune diseases. The colon has a higher pH than the rest of the gastrointestinal tract (GIT) and this ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro-Ruíz, Eva, Álvarez-Álvarez, Covadonga, Peña, M Ángeles, Torrado-Salmerón, Carlos, Dahma, Zaid, de la Torre-Iglesias, Paloma Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322124/ https://www.ncbi.nlm.nih.gov/pubmed/35890399 http://dx.doi.org/10.3390/pharmaceutics14071504

Ejemplares similares

Multiparticulate System for Colon Targeted Delivery of Ondansetron
por: Jose, S., et al.
Publicado: (2010)

Multiparticulate Systems of Ezetimibe Micellar System and Atorvastatin Solid Dispersion Efficacy of Low-Dose Ezetimibe/Atorvastatin on High-Fat Diet-Induced Hyperlipidemia and Hepatic Steatosis in Diabetic Rats
por: Torrado-Salmerón, Carlos, et al.
Publicado: (2021)

Acceptability of placebo multiparticulate formulations in children and adults
por: Lopez, Felipe L., et al.
Publicado: (2018)

Oral Meloxicam Administration in Sows at Farrowing and Its Effects on Piglet Immunity Transfer and Growth
por: Navarro, Elena, et al.
Publicado: (2021)

A Novel Oral Syringe for Dosing and Administration of Multiparticulate Formulations: Acceptability Study in Preschool and School Children
por: Katarzyna Hofmanová, Justyna, et al.
Publicado: (2020)

Formulation and evaluation of multiparticulate system for chronotherapeutic delivery of salbutamol sulphate
por: Chaudhari, Pallavi M., et al.
Publicado: (2012)

Mucoadhesive Multiparticulate Drug Delivery Systems: An Extensive Review of Patents
por: Komati, Someshwar, et al.
Publicado: (2019)

Development and in vitro Evaluation of Enteric Coated Multiparticulate System for Resistant Tuberculosis
por: Rahman, Md. A., et al.
Publicado: (2008)

Development of orally disintegrating tablets comprising controlled-release multiparticulate beads
por: Venkatesh, Gopi M., et al.
Publicado: (2012)

Preparation and Characterization of a Novel Multiparticulate Dosage Form Carrying Budesonide-Loaded Chitosan Nanoparticles to Enhance the Efficiency of Pellets in the Colon
por: Soltani, Fatemeh, et al.
Publicado: (2022)

Pharmaceutical and pharmacokinetic evaluation of a newly formulated multiparticulate matrix of levodopa and carbidopa
por: Imbeah, Emelia Priscilla, et al.
Publicado: (2022)

Repeated administration of the NSAID meloxicam alters the plasma and urine lipidome
por: Rivera-Velez, Sol M., et al.
Publicado: (2019)

The Evaluation of Meloxicam Nanocrystals by Oral Administration with Different Particle Sizes
por: Yu, Yao, et al.
Publicado: (2022)

Development of Chitosan/Sodium Carboxymethylcellulose Complexes to Improve the Simvastatin Release Rate: Polymer/Polymer and Drug/Polymer Interactions’ Effects on Kinetic Models
por: López-Manzanara Pérez, Celia, et al.
Publicado: (2023)

Rabeprazole sodium delayed-release multiparticulates: Effect of enteric coating layers on product performance
por: Tirpude, Rakesh N., et al.
Publicado: (2011)

Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery
por: Mehanna, Mohammed M, et al.
Publicado: (2019)

Impact of Surface Properties of Core Material on the Stability of Hot Melt-Coated Multiparticulate Systems
por: Schertel, Sonja, et al.
Publicado: (2021)

A Pharmacokinetic Evaluation of a Pectin-Based Oral Multiparticulate Matrix Carrier of Carbamazepine
por: Amponsah, Seth Kwabena, et al.
Publicado: (2021)

Acceptability of Multiparticulate Dosing Using Sympfiny(®) Delivery System with Children (Age 1–12)
por: Abeln, Kate, et al.
Publicado: (2022)

Pharmacokinetics of meloxicam in pigeons after single intravenous, oral, and intramuscular administration
por: Chen, Jun-Cheng, et al.
Publicado: (2023)

Meloxicam inhibits STING phosphorylation and alleviates intracellular DNA-mediated autoimmune responses
por: Yu, Yu, et al.
Publicado: (2023)

Efficiency of Multiparticulate Delivery Systems Loaded with Flufenamic Acid Designed for Burn Wound Healing Applications
por: Dinescu, Sorina, et al.
Publicado: (2019)

Meloxicam-Induced Pancreatitis
por: Landa, Eric, et al.
Publicado: (2021)

Meloxicam hydrochloride
por: Flores Manuel, Fermin, et al.
Publicado: (2023)

Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose
por: de la Torre-Iglesias, Paloma Marina, et al.
Publicado: (2014)

The effect of surgery (Ovariohysterectomy) on the plasma disposition of meloxicam following intravenous administration in dogs
por: Karademir, Umit, et al.
Publicado: (2016)

Pharmacokinetics of meloxicam after oral administration of a granule formulation to healthy horses
por: Mendoza, Francisco Javier, et al.
Publicado: (2019)

Pharmacokinetics of the Anti-Inflammatory Drug Meloxicam after Single 1.5 mg/kg Intramuscular Administration to Undulate Skates (Raja undulata)
por: Morón-Elorza, Pablo, et al.
Publicado: (2022)

Quality by Design Based Formulation Study of Meloxicam-Loaded Polymeric Micelles for Intranasal Administration
por: Sipos, Bence, et al.
Publicado: (2020)

Impact of Meloxicam Administration in Cows Prior to Caesarean Section on the Efficacy of Passive Immunity Transfer in Calves
por: Guatteo, Raphaël, et al.
Publicado: (2022)

Stability Indicating HPTLC Determination of Meloxicam
por: Desai, Namita, et al.
Publicado: (2008)

Bioavailability and pharmacokinetics of oral meloxicam in llamas
por: Kreuder, Amanda J, et al.
Publicado: (2012)

A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation
por: Rampedi, Penelope N., et al.
Publicado: (2022)

Electroencephalographic Changes Associated with Antinociceptive Actions of Lidocaine, Ketamine, Meloxicam, and Morphine Administration in Minimally Anaesthetized Dogs
por: Kaka, Ubedullah, et al.
Publicado: (2015)

Efficacy and safety of co-administration of resveratrol with meloxicam in patients with knee osteoarthritis: a pilot interventional study
por: Hussain, Saad Abdulrahman, et al.
Publicado: (2018)

Postpartum meloxicam administration alters plasma haptoglobin, polyunsaturated fatty acid, and oxylipid concentrations in postpartum ewes
por: Olagaray, Katie E., et al.
Publicado: (2020)

The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics
por: Van Engen, Nicholas K, et al.
Publicado: (2019)

Meloxicam and Dexamethasone Administration as Anti-Inflammatory Compounds to Sows Prior to Farrowing Does Not Improve Lactation Performance
por: Plush, Kate J., et al.
Publicado: (2021)

Optimization of the sonication process for meloxicam nanocrystals preparation
por: IURIAN, SONIA, et al.
Publicado: (2015)

Pharmaceutical Salts of Piroxicam and Meloxicam with Organic Counterions
por: Huang, Shan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_33k70ck4sjuevm9p9doju30a92